In other words, the gradient of NRP-1 and VEGFR-2 expression between the tumor and peritumoral tissue may attract VEGFA into the peritumoral tissue, where it combines with peritumoral NRP-1 and VEGFR-2 in hepatocytes, which may decrease tumor endothelial cell proliferation. Here, VEGFA is linked to neoplasm.